Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain.
Ortiz-de-Lejarazu Leonardo R, Díez Domingo J, de Miguel ÁG, Martinón Torres F, Margüello ER, López-Belmonte Claver JL, Palomo-Jiménez PI, Farré Avellà JM, Abellán Perpiñán JM. Ortiz-de-Lejarazu Leonardo R, et al. Among authors: de miguel ag. BMC Infect Dis. 2025 Feb 1;25(1):152. doi: 10.1186/s12879-025-10442-3. BMC Infect Dis. 2025. PMID: 39893473 Free PMC article.
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain.
Martinón-Torres F, de Miguel ÁG, Ruiz-Contreras J, Vallejo-Aparicio LA, García A, Gonzalez-Inchausti MC, de Gomensoro E, Kocaata Z, Gabás-Rivera C, Comellas M, Prades M, Lizán L. Martinón-Torres F, et al. Among authors: de miguel ag. Infect Dis Ther. 2023 Jan;12(1):157-175. doi: 10.1007/s40121-022-00708-7. Epub 2022 Nov 11. Infect Dis Ther. 2023. PMID: 36367677 Free PMC article.
A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months.
Díez-Domingo J, Cantarino MV, Torrentí JM, Sansano MI, Rosich AJ, Merino AH, de Miguel AG, González JB, Marcos MD; MenC Study Group. Díez-Domingo J, et al. Among authors: de miguel ag. Pediatr Infect Dis J. 2010 Feb;29(2):148-52. doi: 10.1097/INF.0b013e3181b9a831. Pediatr Infect Dis J. 2010. PMID: 19927040 Clinical Trial.
Coverage and predictors of influenza vaccination among adults with diabetes in Spain.
Jiménez-García R, Jimenez I, Garrido PC, Hernández-Barrera V, de Andres AL, del Barrio JL, de Miguel AG. Jiménez-García R, et al. Among authors: de miguel ag, de andres al. Diabetes Res Clin Pract. 2008 Mar;79(3):510-7. doi: 10.1016/j.diabres.2007.10.013. Epub 2007 Nov 26. Diabetes Res Clin Pract. 2008. PMID: 18035444
Coverage and predictors of influenza vaccination among adults living in a large metropolitan area in Spain: a comparison between the immigrant and indigenous populations.
Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, de Andres AL, Esteban y Peña MM, de Miguel AG. Jiménez-García R, et al. Among authors: de miguel ag, de andres al. Vaccine. 2008 Aug 5;26(33):4218-23. doi: 10.1016/j.vaccine.2008.05.053. Epub 2008 Jun 6. Vaccine. 2008. PMID: 18579263
64 results